share_log

Have EHealth Insiders Been Selling Stock?

Have EHealth Insiders Been Selling Stock?

易康内部人员是否在出售股票?
Simply Wall St ·  2024/11/16 04:05

Anyone interested in eHealth, Inc. (NASDAQ:EHTH) should probably be aware that the Independent Director, Dale Wolf, recently divested US$105k worth of shares in the company, at an average price of US$5.25 each. That sale was 14% of their holding, so it does make us raise an eyebrow.

任何对易康公司(纳斯达克:EHTH)感兴趣的人可能应该知道,独立董事戴尔·沃尔夫最近出售了价值105000美元的股份,平均售价为每股5.25美元。这次出售占他们持股的14%,因此确实让我们 raised an eyebrow。

The Last 12 Months Of Insider Transactions At eHealth

过去12个月的内部交易情况

The CEO & Director Francis Soistman made the biggest insider purchase in the last 12 months. That single transaction was for US$204k worth of shares at a price of US$4.07 each. Even though the purchase was made at a significantly lower price than the recent price (US$4.78), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

首席执行官兼董事弗朗西斯·索伊斯特曼在过去的12个月中进行了最大的内部购买。该笔交易为204000美元,购买价格为每股4.07美元。尽管该购买的价格显著低于近期价格(4.78美元),但我们仍然认为内部买入是积极的。因为股票是在更低的价格下购买的,这笔买入对我们了解内部人士对当前股价的看法帮助不大。

Happily, we note that in the last year insiders paid US$358k for 87.37k shares. On the other hand they divested 20.00k shares, for US$105k. In total, eHealth insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

令人欣慰的是,我们注意到在过去的一年里,内部人士为87370股支付了358000美元。另一方面,他们出售了20000股,价值105000美元。总的来说,易康的内部人士在过去一年中购买的股份超过了出售的股份。您可以在下面的图表中查看过去一年内部交易(由公司和个人)情况。通过点击下面的图形,您可以查看每笔内部交易的详细信息!

big
NasdaqGS:EHTH Insider Trading Volume November 16th 2024
纳斯达克GS:EHTH 内部交易量 2024年11月16日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

还有很多其他的公司,公司的内部人士正在购买股票。你可能不想错过这个免费的小市值公司的低估列表。

Insider Ownership Of eHealth

易康的内部持股

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Our data indicates that eHealth insiders own about US$7.3m worth of shares (which is 5.1% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

查看公司内部总持股可以帮助你了解他们是否与普通股东有良好的利益一致性。我们通常希望看到相对较高的内部持股水平。我们的数据表明,易康的内部人士持有约730万美元的股票(占公司5.1%)。总体而言,这一持股水平并不是很令人印象深刻,但总比没有好!

So What Does This Data Suggest About eHealth Insiders?

那么这些数据对易康的内部人士意味着什么呢?

The insider sales have outweighed the insider buying, at eHealth, in the last three months. In contrast, they appear keener if you look at the last twelve months. But we'd like it if insiders owned more stock, overall. So the company doesn't look great on this analysis. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 3 warning signs for eHealth you should be aware of.

在过去三个月里,易康的内部出售超过了内部购买。相比之下,如果你看过去十二个月,他们似乎更积极。不过,我们希望内部人士能拥有更多的股票,总体来看公司在这个分析上并不出色。因此,这些内部交易可以帮助我们构建对股票的分析论文,但了解该公司面临的风险也是值得的。举个例子:我们发现了易康的3个警告信号,你应该注意。

Of course eHealth may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,易康可能不是最佳的买入股票。因此你可能希望看看这份高质量公司的免费集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发